ArticleScientific reports2026
Co-occurrence of plasmid-mediated colistin resistance gene, mcr-1 and bla
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colistin, a “last-resort” antibiotic for treatment of human infections caused by multidrug-resistant (MDR) Gram-negative bacteria, has been widely used in veterinary medicine for decades. Farm animals have been identified as a significant reservoir of mcr-1-carrying bacteria with potential zoonotic transmission. This study aimed to characterize mcr-1-positive Escherichia coli isolates obtained from calves in Iran. Rectal swab samples were collected from both diarrhetic and healthy calves and screened for colistin-resistant bacteria. The presence of colistin resistance genes mcr-1 to 5 was examined using PCR. The genomic features of 15 out of 82 colistin resistant isolates were further studied by whole -genome sequencing. All isolates carried mcr-1.1 variant and belonged to ST224 (n = 3), ST162 (n = 2), ST167 (n = 2), ST1642 (n = 2), ST949 (n = 2), ST617, ST5229, ST88 and ST2345 (n = 1 each). These isolates exhibited high rates of resistance to ceftazidime, cefepime, and sulfamethoxazole-trimethoprim (100%), followed by tetracyclines, chloramphenicol, gentamicin, ciprofloxacin (≥ 80%) and amikacin (60%) mediated by the presence of blaCTX−M, sul and dfrA variants, tetA/B/M, floR/cmlA1, aac(3)-IId/a or ant(2’’)-Ia, qnrS, aac(6’)-Ib-cr, gyrA (S83L, D87N), and parC (S80I) mutations and rmtB gene. All isolates were susceptible to tigecycline, nitrofurantoin and imipenem. The IncI2 (delta) replicon was the most prevalent plasmid type among the studied isolates, suggesting it may play a key role in mcr-1 dissemination. The mcr-1- associated elements and colistin resistance phenotype remained stable following 10 days of passage in the absence of colistin pressure. This study reports isolation of mcr-1-bearing-MDR E. coli isolates co-harboring blaCTX−M and rmtB genes from animal sources. The observed clonal diversity among mcr-1-positive-isolates suggests a potential role for epidemic plasmids including IncI2, in the dissemination of mcr-1 gene in farm animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.